Distribuzione geografica
Continente #
NA - Nord America 645
EU - Europa 109
AS - Asia 14
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 779
Nazione #
US - Stati Uniti d'America 637
IT - Italia 39
GB - Regno Unito 15
DE - Germania 14
FR - Francia 9
RU - Federazione Russa 9
CA - Canada 7
IN - India 7
BE - Belgio 6
ZA - Sudafrica 6
CZ - Repubblica Ceca 5
EG - Egitto 3
NL - Olanda 3
CH - Svizzera 2
CN - Cina 2
ES - Italia 2
ID - Indonesia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
GR - Grecia 1
HK - Hong Kong 1
HU - Ungheria 1
MX - Messico 1
RO - Romania 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
Totale 779
Città #
Santa Cruz 78
Fairfield 73
Seattle 46
Woodbridge 36
Ashburn 34
Houston 31
Wilmington 29
Buffalo 28
Cambridge 22
Bologna 20
Boardman 12
Southend 10
Ann Arbor 9
Las Vegas 9
Los Angeles 9
Muizenberg 6
Riva 6
Chicago 5
Phoenix 5
Provo 5
Clearwater 4
Henderson 4
San Diego 4
San Francisco 4
Cairo 3
Harderwijk 3
Leipzig 3
Milpitas 3
New York 3
Ottawa 3
Redmond 3
Scranton 3
Auburn 2
Barcelona 2
Cassino 2
Dallas 2
Jakarta 2
Mountain View 2
Palo Alto 2
Toronto 2
Ankara 1
Annapolis 1
Austin 1
Bellevue 1
Benevento 1
Brescia 1
Brockport 1
Brussels 1
Büdelsdorf 1
Casalecchio Di Reno 1
Chandler 1
Changsha 1
Costabissara 1
Dulles 1
Forlì 1
Huddersfield 1
Imola 1
Jacksonville 1
Lake Forest 1
Lille 1
Lodi 1
Lombard 1
London 1
Media 1
Mississauga 1
Montreal 1
Natick 1
Norwalk 1
Philadelphia 1
Portland 1
Pregassona 1
Ravenna 1
Rochester 1
Rome 1
Saint Paul 1
Saint Petersburg 1
San Pablo 1
Santiago 1
Scarsdale 1
Scottsdale 1
Shanghai 1
Tsuen Wan 1
University Park 1
Zurich 1
Totale 573
Nome #
Prevalence of and risk factors for fatty liver in the general population of Northern Italy: The Bagnacavallo Study, file e1dcb333-00b3-7715-e053-1705fe0a6cc9 92
Multidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver Disease, file e1dcb32e-1c90-7715-e053-1705fe0a6cc9 89
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels., file e1dcb32c-40b1-7715-e053-1705fe0a6cc9 85
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network., file e1dcb333-986c-7715-e053-1705fe0a6cc9 69
Monitoring the treatment of hepatitis C with directly acting antivirals by serological and molecular methods, file e1dcb330-923b-7715-e053-1705fe0a6cc9 67
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy, file e1dcb333-73da-7715-e053-1705fe0a6cc9 65
Impact of psychosocial status on liver transplant process, file e1dcb337-37ff-7715-e053-1705fe0a6cc9 49
Current and forthcoming perspectives in linkage to care of hepatitis C virus infection: Assessment of an Italian focus group, file e1dcb336-dad3-7715-e053-1705fe0a6cc9 44
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways, file e1dcb32d-ded1-7715-e053-1705fe0a6cc9 39
Insights into cancer severity from biomolecular interaction mechanisms, file e1dcb336-050c-7715-e053-1705fe0a6cc9 39
Hcverso1 and 2: Faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection, file e1dcb336-08ef-7715-e053-1705fe0a6cc9 30
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial, file e1dcb337-db42-7715-e053-1705fe0a6cc9 30
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis., file e1dcb32c-6266-7715-e053-1705fe0a6cc9 25
Alcohol and viral hepatitis: a mini-review., file e1dcb32b-d05e-7715-e053-1705fe0a6cc9 11
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies, file e1dcb32f-68ee-7715-e053-1705fe0a6cc9 7
Vitamins in the treatment of chronic viral hepatitis., file e1dcb32c-121e-7715-e053-1705fe0a6cc9 5
Adaptive response in Hepatitis B virus infection, file e1dcb32c-5072-7715-e053-1705fe0a6cc9 5
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score, file e1dcb339-9033-7715-e053-1705fe0a6cc9 5
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial, file e1dcb32d-874c-7715-e053-1705fe0a6cc9 4
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study., file e1dcb32f-4523-7715-e053-1705fe0a6cc9 4
Sustained virologic response rates with telaprevir by response after 4weeks of lead-in therapy in patients with prior treatment failure, file e1dcb32c-694e-7715-e053-1705fe0a6cc9 3
ABT-450: A novel agent for the treatment of CHC genotype 1: Focus on treatment-experienced patients, file e1dcb32e-2ece-7715-e053-1705fe0a6cc9 3
null, file e1dcb32f-92aa-7715-e053-1705fe0a6cc9 3
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice, file e1dcb32f-c5b6-7715-e053-1705fe0a6cc9 3
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance., file e1dcb32b-fd5f-7715-e053-1705fe0a6cc9 2
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C., file e1dcb32c-1922-7715-e053-1705fe0a6cc9 2
Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension, file e1dcb32c-4c24-7715-e053-1705fe0a6cc9 2
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C., file e1dcb32c-50b1-7715-e053-1705fe0a6cc9 2
Metronomic capecitabine in advanced hepatocellular carcinoma patients:a phase II study., file e1dcb32d-42f6-7715-e053-1705fe0a6cc9 2
De novo autoimmune hepatitis in liver transplant: State-of-the-art review, file e1dcb32d-dd2c-7715-e053-1705fe0a6cc9 2
Liver Stiffness measurments using Fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients., file e1dcb32f-bb96-7715-e053-1705fe0a6cc9 2
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients, file e1dcb330-1c0b-7715-e053-1705fe0a6cc9 2
DAAs treatment in HCV recurrence after liver transplantation: Clinical usefulness of non-invasive methods, file e1dcb330-22e9-7715-e053-1705fe0a6cc9 2
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study, file e1dcb330-2929-7715-e053-1705fe0a6cc9 2
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation., file e1dcb32b-d29e-7715-e053-1705fe0a6cc9 1
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems, file e1dcb32b-e57d-7715-e053-1705fe0a6cc9 1
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection., file e1dcb32b-ecbf-7715-e053-1705fe0a6cc9 1
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival., file e1dcb32c-0a61-7715-e053-1705fe0a6cc9 1
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin, file e1dcb32c-0a67-7715-e053-1705fe0a6cc9 1
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin., file e1dcb32c-4a54-7715-e053-1705fe0a6cc9 1
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report., file e1dcb32c-5041-7715-e053-1705fe0a6cc9 1
A new prognostic model to predict drop-out from the waiting list in cirrhotic candidates for liver transplantation wirh MELD score <18., file e1dcb32c-5073-7715-e053-1705fe0a6cc9 1
Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial, file e1dcb32c-6439-7715-e053-1705fe0a6cc9 1
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin, file e1dcb32c-6948-7715-e053-1705fe0a6cc9 1
Predicting Early and Sustained Virological Responses in Prior Nonresponders to Pegylated Interferon alpha-2b Plus Ribavirin Retreated With Peginterferon alpha-2a Plus Ribavirin and the Benefit-Risk Ratio of Retreatment, file e1dcb32c-6949-7715-e053-1705fe0a6cc9 1
Chronic hepatitis B: Are we close to a cure?, file e1dcb32c-c329-7715-e053-1705fe0a6cc9 1
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection., file e1dcb32d-8e02-7715-e053-1705fe0a6cc9 1
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies, file e1dcb32e-8308-7715-e053-1705fe0a6cc9 1
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature, file e1dcb32e-990f-7715-e053-1705fe0a6cc9 1
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study., file e1dcb32e-aafd-7715-e053-1705fe0a6cc9 1
What to start with in first line treatment of chronic hepatitis B patients: an Italian multicentre observational cohort, HBV-RER study group., file e1dcb330-fcd7-7715-e053-1705fe0a6cc9 1
A New Two-Dimensional Shear Wave Elastography for Noninvasive Assessment of Liver Fibrosis in Healthy Subjects and in Patients with Chronic Liver Disease - Eine neue zweidimensionale Shear-Wave-Elastografie zur nicht-invasiven Beurteilung der Leberfibrose bei Gesunden und bei Patienten mit chronischer Lebererkrankung, file e1dcb332-5a78-7715-e053-1705fe0a6cc9 1
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals, file e1dcb332-82ab-7715-e053-1705fe0a6cc9 1
null, file e1dcb337-51bc-7715-e053-1705fe0a6cc9 1
Totale 816
Categoria #
all - tutte 1523
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1523

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182 0000 00 01 1000
2018/201910 0000 14 11 1002
2019/2020179 0007 2326 2527 3215168
2020/2021158 101366 139 99 3026198
2021/2022284 691617 349 924 14710138
2022/2023171 24369912 00 00 0000
Totale 816